These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 37496101)

  • 1. Occurrence and outcome of COVID-19 in AIRD patients on concomitant treatment with Tofacitinib- results from KRA COVID COHORT (KRACC) subset.
    Chebbi P; Shobha V; Rao VK; Haridas V; Janardana R; Pinto B; Kumar S; Patil A; Tekkatte R; Salanke M; Mahendranath KM
    BMC Rheumatol; 2023 Jul; 7(1):22. PubMed ID: 37496101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 Pandemic on Patients With Rheumatic Diseases in Medina, Saudi Arabia: An Observational Cross-Sectional Study.
    Safar Alsofyani I; Samman BS; Alhubayshi SS; Ellahi AT; Alsaedi AB; Almansour M
    Cureus; 2024 May; 16(5):e60128. PubMed ID: 38864060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19 : A Binational Cohort Study.
    Kim MS; Lee H; Lee SW; Kwon R; Rhee SY; Lee JA; Koyanagi A; Smith L; Fond G; Boyer L; Lee J; Rahmati M; Shin JY; Min C; Shin JI; Yon DK
    Ann Intern Med; 2024 Mar; 177(3):291-302. PubMed ID: 38437702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4/CD8 Ratio: An Independent Predictor of Herpes Zoster in Patients With Autoimmune Inflammatory Rheumatic Diseases.
    Liu PC; Peng YL; Li JB; Lv MN; Yu SJ; Wu R
    Ann Dermatol; 2024 Jun; 36(3):163-171. PubMed ID: 38816977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and autoimmune rheumatic disease: behavioural changes adopted by patients amid the pandemic.
    Dey D; Katso B; Issaka S; Adjei P
    Intern Med J; 2024 May; ():. PubMed ID: 38816941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Tofacitinib in Anti-Melanoma Differentiation-Associated 5 Gene Antibody-Positive Dermatomyositis.
    Li S; Li S; Wang J; Zhang L; Duan J; Lu X; Zhang L; Wang G
    J Clin Rheumatol; 2023 Sep; 29(6):281-284. PubMed ID: 37496128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19.
    Kooistra EJ; Dahm K; van Herwaarden AE; Gerretsen J; Nuesch Germano M; Mauer K; Smeets RL; van der Velde S; van den Berg MJW; van der Hoeven JG; Aschenbrenner AC; Schultze JL; Ulas T; Kox M; Pickkers P
    Respir Res; 2023 Aug; 24(1):196. PubMed ID: 37559053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of COVID-19 patients with Guillain-Barre, Miller-Fisher, and opsoclonus-myoclonus-ataxia syndromes-a case series.
    Olbert E; Alhani N; Struhal W
    Wien Med Wochenschr; 2024 Feb; 174(1-2):30-34. PubMed ID: 37523107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of JAK inhibitors on enthesitis in spondyloarthropathy: A scoping literature review.
    Jubber A; Tahir H; Moorthy A
    Musculoskeletal Care; 2023 Dec; 21(4):1195-1203. PubMed ID: 37501580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant replacement therapy as promising treatment for COVID-19: an updated narrative review.
    Khudadah K; Ramadan A; Othman A; Refaey N; Elrosasy A; Rezkallah A; Heseba T; Moawad MHED; Mektebi A; Elejla SA; Abouzid M; Abdelazeem B
    Biosci Rep; 2023 Aug; 43(8):. PubMed ID: 37497603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of T-cell-Epstein-Barr virus-haemophagocytic lymphohistiocytosis and sustained remission following ruxolitinib therapy.
    Ali S; Choo S; Hosking L; Smith A; Hughes T
    Clin Transl Immunology; 2023; 12(7):e1459. PubMed ID: 37497193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Inactivated SARS-CoV-2 Vaccines Among Adults with Experience of Allergies to Food or Medicines.
    Jin Y; Zheng M; He S; Chen M; Cao C
    Int J Gen Med; 2023; 16():3105-3113. PubMed ID: 37496598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and Zinc Supplementation to Improve Treatment Outcomes among COVID-19 Patients in India: Results from a Double-Blind Randomized Placebo-Controlled Trial.
    Partap U; Sharma KK; Marathe Y; Wang M; Shaikh S; D'Costa P; Gupta G; Bromage S; Hemler EC; Mistry N; Kain KC; Dholakia Y; Fawzi WW
    Curr Dev Nutr; 2023 Aug; 7(8):101971. PubMed ID: 37560461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs.
    Rasizadeh R; Aghbash PS; Nahand JS; Entezari-Maleki T; Baghi HB
    Virol J; 2023 Aug; 20(1):179. PubMed ID: 37559103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis.
    Shafiee A; Amini MJ; Arabzadeh Bahri R; Jafarabady K; Salehi SA; Hajishah H; Mozhgani SH
    Eur J Med Res; 2023 Aug; 28(1):278. PubMed ID: 37559096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis.
    Guinto E; Gerayeli FV; Eddy RL; Lee H; Milne S; Sin DD
    Eur Respir Rev; 2023 Sep; 32(169):. PubMed ID: 37558261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study.
    Mujukian A; Kumar R; Li D; Debbas P; Botwin GJ; Cheng S; Ebinger J; Braun J; McGovern D; Melmed GY;
    Inflamm Bowel Dis; 2024 Apr; 30(4):602-616. PubMed ID: 37556401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccination and Gout Flare Risk in Patients With Infrequent or Frequent Flares: A Prospective Cohort Study.
    He Y; Xue X; Dalbeth N; Terkeltaub R; Chen Y; Yan F; Pang L; Li X; Yuan X; Cheng X; Li C; Sun M
    Arthritis Care Res (Hoboken); 2024 Jan; 76(1):131-139. PubMed ID: 37553607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in clinical characteristics and liver injury between patients diagnosed with the Omicron subvariant BA.5.2 and the prototype of SARS-CoV-2: a single center retrospective study.
    Li J; Zhang Q; Xu C; Zhang Y; Lu Y; Ai M; Tan X
    BMC Gastroenterol; 2023 Aug; 23(1):271. PubMed ID: 37553605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital home monitoring for capturing daily fluctuation of symptoms; a longitudinal repeated measures study: Long Covid Multi-disciplinary Consortium to Optimise Treatments and Services across the NHS (a LOCOMOTION study).
    Mansoubi M; Dawes J; Bhatia A; Vashisht H; Collett J; Greenwood DC; Ezekiel L; O'Connor D; Leveridge P; Rayner C; Read F; Sivan M; Tuckerbell I; Ward T; Delaney B; Muhlhausen W; ; Dawes H
    BMJ Open; 2023 Aug; 13(8):e071428. PubMed ID: 37553189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.